Caplin Point Laboratories planning to enter in business transfer agreement

02 Jan 2019 Evaluate

Caplin Point Laboratories is planning for the Business Transfer Agreement to be entered into with its Wholly Owned Subsidiary Company, Caplin Steriles, for transfer of business undertaking of the Company (Regulated Markets Injectable Business, including USFDA approved Injectable Plant and DSIR recognized R&D Units CP4 and CP5). The meeting of the Board of Directors of the Company is scheduled to be held on January 11, 2019, to consider the same.

Caplin Point Laboratories is engaged mainly in manufacturing a wide range of Ointments, Creams and other External application preparations in addition to the regular segments of pharmaceutical formulations.

Caplin Point Lab Share Price

1963.05 -13.80 (-0.70%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×